X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6) 6
ipilimumab (6) 6
melanoma (6) 6
braf inhibitor (5) 5
immunotherapy (5) 5
index medicus (5) 5
targeted therapy (5) 5
antibodies, monoclonal - therapeutic use (4) 4
melanoma - drug therapy (4) 4
antibodies, monoclonal - adverse effects (3) 3
antineoplastic agents - adverse effects (3) 3
antineoplastic agents - therapeutic use (3) 3
dermatology (3) 3
drug therapy (3) 3
female (3) 3
mek inhibitor (3) 3
middle aged (3) 3
side effects (3) 3
skin cancer (3) 3
adult (2) 2
aged (2) 2
aged, 80 and over (2) 2
autoimmune diseases (2) 2
cancer (2) 2
chemotherapy (2) 2
kaplan-meier estimate (2) 2
lymphocytes (2) 2
male (2) 2
medical prognosis (2) 2
medicine (2) 2
melanoma - mortality (2) 2
melanoma - secondary (2) 2
metastases (2) 2
metastasis (2) 2
multidisciplinary sciences (2) 2
mutation (2) 2
mutation analysis (2) 2
oncology (2) 2
patients (2) 2
safety (2) 2
skin neoplasms - drug therapy (2) 2
small molecules (2) 2
treatment outcome (2) 2
trial (2) 2
abridged index medicus (1) 1
adjuvant (1) 1
adverse event (1) 1
adverse events (1) 1
algorithms (1) 1
anti-ctla-4 (1) 1
anti-ctla-4-antibodies (1) 1
antibodies, monoclonal - immunology (1) 1
antigens (1) 1
antigens, cd - immunology (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - immunology (1) 1
antitumor activity (1) 1
anti‐ctla‐4‐antibodies (1) 1
article (1) 1
articles (1) 1
aseptic meningitis (1) 1
aufsatzsammlung (1) 1
autoimmunity (1) 1
biomedical research - trends (1) 1
blocking antibodies (1) 1
braf-inhibitors (1) 1
cancer vaccines - adverse effects (1) 1
cancer vaccines - therapeutic use (1) 1
care and treatment (1) 1
central nervous system (1) 1
clinical studies (1) 1
clinical trials (1) 1
clinical-response (1) 1
combined modality therapy (1) 1
competition (1) 1
competition history (1) 1
competition, international (1) 1
competition, international history (1) 1
conjunctival (1) 1
criteria (1) 1
ctla-4 antigen (1) 1
ctla-4 antigen - immunology (1) 1
ctla-4 blockade (1) 1
ctla-4 protein (1) 1
cytokines (1) 1
cytotoxicity (1) 1
dermatology - trends (1) 1
developmental biology (1) 1
disease control (1) 1
dosage (1) 1
dose-escalation (1) 1
double-blind (1) 1
double-blind method (1) 1
drug eruptions - diagnosis (1) 1
drug eruptions - etiology (1) 1
drug eruptions - prevention & control (1) 1
développement politique (1) 1
economic development (1) 1
economic development history (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2010, Volume 363, Issue 8, pp. 711 - 723
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2015, Volume 10, Issue 3, pp. e0118564 - e0118564
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, pp. e53745 - e53745
Background: Ipilimumab, a cytotoxic T-lymphocyte antigen-4 (CTLA-4) blocking antibody, has been approved for the treatment of metastatic melanoma and induces... 
REGRESSION | TRIAL | INDUCED SARCOIDOSIS | CTLA-4 BLOCKADE | AUTOIMMUNITY | SAFETY | MULTIDISCIPLINARY SCIENCES | MONOCLONAL-ANTIBODY | PATIENT | HYPOPHYSITIS | CANCER | Skin Neoplasms - drug therapy | Humans | Ipilimumab | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Neoplasm Metastasis | Liver - drug effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Endocrine System - drug effects | Adult | Female | Retrospective Studies | Antibodies, Monoclonal - immunology | Kidney - drug effects | Antineoplastic Agents - immunology | Pancreas - drug effects | Gastrointestinal Tract - drug effects | Melanoma - pathology | CTLA-4 Antigen - immunology | Nervous System - drug effects | Melanoma - drug therapy | Respiratory System - drug effects | Aged | Skin - drug effects | Antimitotic agents | Antigens | Care and treatment | Algorithms | Lymphocytes | Melanoma | Skin | Metastasis | Antineoplastic agents | Skin cancer | Cancer | Aseptic meningitis | Guillain-Barre syndrome | Exanthema | Central nervous system | Blocking antibodies | Cytotoxicity | Oncology | Lymphocytes T | Metastases | CTLA-4 protein | Intestine | Gastroenterology | Meningitis | Internal medicine | Hematology | Sarcoidosis | Dermatology | Management | Regression analysis | Patients | Eosinophilia | Morbidity | Inflammatory bowel disease | Pathology | Side effects | Hospitals | Perforations | Medical prognosis | Antitumor activity | Autoimmune diseases | Endocrinology | Index Medicus
Journal Article
JDDG - Journal of the German Society of Dermatology, ISSN 1610-0379, 07/2012, Volume 10, Issue 7, pp. 475 - 486
Journal Article
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 07/2012, Volume 10, Issue 7, pp. 475 - 487
Journal Article
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 07/2012, Volume 10, Issue 7, pp. 475 - 486
The discovery of specific gene mutations, termed “driver mutations”, in different tumors has brought personalized medicine into the focus of cancer treatment.... 
targeted therapy | side effects | BRAF inhibitor | MEK inhibitor | chemotherapy | ipilimumab | Drug Eruptions - etiology | Drug Eruptions - prevention & control | Antineoplastic Agents - adverse effects | Drug Eruptions - diagnosis | Humans | Drug therapy | Dermatology | Mutation
Journal Article
JDDG - Journal of the German Society of Dermatology, ISSN 1610-0379, 05/2012, Volume 10, Issue 5, pp. 319 - 325
Journal Article
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 05/2012, Volume 10, Issue 5, pp. 319 - 325
Journal Article
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 12/2013, Volume 11, Issue 12, pp. 1220 - 1221
Journal Article
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 07/2012, Volume 10, Issue 7, pp. 475 - 487
Journal Article
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 07/2012, Volume 10, Issue 7, pp. 475 - 486
Journal Article
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 05/2012, Volume 10, Issue 5, pp. 319 - 325
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2014, Volume 32, Issue 15, pp. 9031 - 9031
Conference Proceeding
Oncology Letters, ISSN 1792-1074, 03/2010, Volume 1, Issue 2, pp. 237 - 241
Although adjuvant high-dose interferon α-2b therapy significantly improves recurrence-free survival vs. observation in high-risk resected melanoma, the overall... 
Peginterferon α-2b | Adjuvant | Interferon α-2b | Immunotherapy | Melanoma
Journal Article
Haut, ISSN 0938-2216, 06/2012, Volume 23, Issue 3, pp. 102 - 107
Journal Article
Chinese Clinical Oncology, ISSN 2304-3865, 2014, Volume 3, Issue 3
Journal Article
Chinese clinical oncology, 09/2014, Volume 3, Issue 3, p. 29
The introduction of tyrosine kinase inhibitors for the treatment of malignant melanoma has led to unprecedented response rates with superior overall survival... 
Journal Article
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 05/2012, Volume 10, Issue 5, pp. 319 - 325
Journal Article